0000315066-18-001774.txt : 20180405
0000315066-18-001774.hdr.sgml : 20180405
20180405122723
ACCESSION NUMBER: 0000315066-18-001774
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180403
FILED AS OF DATE: 20180405
DATE AS OF CHANGE: 20180405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FMR LLC
CENTRAL INDEX KEY: 0000315066
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38443
FILM NUMBER: 18739899
BUSINESS ADDRESS:
STREET 1: 245 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6175706339
MAIL ADDRESS:
STREET 1: 245 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER NAME:
FORMER CONFORMED NAME: FMR CORP
DATE OF NAME CHANGE: 19920717
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Unum Therapeutics Inc.
CENTRAL INDEX KEY: 0001622229
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465308248
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 CAMBRIDGE PARK DRIVE
STREET 2: SUITE 3100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617-945-5576
MAIL ADDRESS:
STREET 1: 200 CAMBRIDGE PARK DRIVE
STREET 2: SUITE 3100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: Unum Therapeutics, Inc.
DATE OF NAME CHANGE: 20141014
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-04-03
1
0001622229
Unum Therapeutics Inc.
UMRX
0000315066
FMR LLC
245 SUMMER STREET
BOSTON
MA
02210
0
0
0
1
See Remark 1
Common Stock
2018-04-03
4
C
0
349462
A
349462
I
F-Prime Capital Partners Healthcare Fund IV LP
Common Stock
2018-04-03
4
C
0
8601
A
358063
I
F-Prime Capital Partners Healthcare Fund IV LP
Common Stock
2018-04-03
4
P
0
94052
12
A
452115
I
F-Prime Capital Partners Healthcare Fund IV LP
Common Stock
2018-04-03
4
C
0
1890701
A
1890701
I
Impresa Fund III Limited Partnership
Common Stock
2018-04-03
4
C
0
46534
A
1937235
I
Impresa Fund III Limited Partnership
Common Stock
2018-04-03
4
C
0
22682
A
22682
I
F-Prime Capital Partners Healthcare Advisors Fund IV LP
Common Stock
2018-04-03
4
C
0
558
A
23240
I
F-Prime Capital Partners Healthcare Advisors Fund IV LP
Series A Preferred Stock
2018-04-03
4
C
0
548702
D
Common Stock
349462
0
I
F-Prime Capital Partners Healthcare Fund IV LP
Series A Preferred Stock
2018-04-03
4
C
0
2968650
D
Common Stock
1890701
0
I
Impresa Fund III Limited Partnership
Series A Preferred Stock
2018-04-03
4
C
0
35614
D
Common Stock
22682
0
I
F-Prime Capital Partners Healthcare Advisors Fund IV LP
Series B Preferred Stock
2018-04-03
4
C
0
13505
D
Common Stock
8601
0
I
F-Prime Capital Partners Healthcare Fund IV LP
Series B Preferred Stock
2018-04-03
4
C
0
73065
D
Common Stock
46534
0
I
Impresa Fund III Limited Partnership
Series B Preferred Stock
2018-04-03
4
C
0
877
D
Common Stock
558
0
I
F-Prime Capital Partners Healthcare Advisors Fund IV LP
On April 3, 2018, in connection with the completion of the issuer's initial public offering, each 1.5701314513884 shares of Series A and Series B Preferred Stock converted into 1 share of Common Stock.
Remark 1: Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. The address of Abigail P. Johnson is c/o FMR LLC, 245 Summer Street, Boston, MA 02110.
Remark 2: The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the undersigned are the beneficial owners of any securities reported herein.
Remark 3: The general partner of F-Prime Capital Partners Healthcare Fund IV LP is F-Prime Capital Partners Healthcare Advisors Fund IV LP (FPCPHA). FPCPHA is solely managed by Impresa Management LLC, the general partner of its general partner and its investment manager. Impresa Fund III Limited Partnership is solely managed by Impresa Management LLC, its general partner and investment manager. Impresa Management LLC is owned, directly or indirectly, by various shareholders and employees of FMR LLC, including certain members of the Johnson family.
Marc R. Bryant, Duly authorized under Powers of Attorney, by and on behalf of FMR LLC and its direct and indirect subsidiaries, and Abigail P. Johnson
2018-04-04